| The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes DJ Drucker, MA Nauck The Lancet 368 (9548), 1696-1705, 2006 | 4822 | 2006 |
| Biology of incretins: GLP-1 and GIP LL Baggio, DJ Drucker Gastroenterology 132 (6), 2131-2157, 2007 | 4519 | 2007 |
| The biology of incretin hormones DJ Drucker Cell metabolism 3 (3), 153-165, 2006 | 2796 | 2006 |
| Normalization of obesity-associated insulin resistance through immunotherapy S Winer, Y Chan, G Paltser, D Truong, H Tsui, J Bahrami, R Dorfman, ... Nature medicine 15 (8), 921-929, 2009 | 1642 | 2009 |
| Pharmacology, physiology, and mechanisms of incretin hormone action JE Campbell, DJ Drucker Cell metabolism 17 (6), 819-837, 2013 | 1558 | 2013 |
| FTO Obesity Variant Circuitry and Adipocyte Browning in Humans M Claussnitzer, SN Dankel, KH Kim, G Quon, W Meuleman, C Haugen, ... New England Journal of Medicine 373 (10), 895-907, 2015 | 1486 | 2015 |
| Mechanisms of action and therapeutic application of glucagon-like peptide-1 DJ Drucker Cell metabolism 27 (4), 740-756, 2018 | 1374 | 2018 |
| Glucagon-like peptide 1 (GLP-1) TD Müller, B Finan, SR Bloom, D D'Alessio, DJ Drucker, PR Flatt, ... Molecular metabolism 30, 72-130, 2019 | 1339 | 2019 |
| Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study DJ Drucker, JB Buse, K Taylor, DM Kendall, M Trautmann, D Zhuang, ... The Lancet 372 (9645), 1240-1250, 2008 | 1285 | 2008 |
| Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor–dependent and–independent pathways K Ban, MH Noyan-Ashraf, J Hoefer, SS Bolz, DJ Drucker, M Husain Circulation 117 (18), 2340-2350, 2008 | 1255 | 2008 |
| Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line. DJ Drucker, J Philippe, S Mojsov, WL Chick, JF Habener Proceedings of the National Academy of Sciences 84 (10), 3434-3438, 1987 | 1175 | 1987 |
| Induction of intestinal epithelial proliferation by glucagon-like peptide 2. DJ Drucker, P Erlich, SL Asa, PL Brubaker Proceedings of the National Academy of Sciences 93 (15), 7911-7916, 1996 | 1058 | 1996 |
| Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells H Ellingsgaard, I Hauselmann, B Schuler, AM Habib, LL Baggio, DT Meier, ... Nature medicine 17 (11), 1481-1489, 2011 | 1047 | 2011 |
| Glucagon-like peptide-1 receptor is involved in learning and neuroprotection MJ During, L Cao, DS Zuzga, JS Francis, HL Fitzsimons, X Jiao, RJ Bland, ... Nature medicine 9 (9), 1173-1179, 2003 | 989 | 2003 |
| Glucose intolerance but normal satiety in mice with a null mutation in the glucagon–like peptide 1 receptor gene LA Scrocchi, TJ Brown, N MaClusky, PL Brubaker, AB Auerbach, ... Nature medicine 2 (11), 1254-1258, 1996 | 963 | 1996 |
| Predicting cardiac complications in patients undergoing non-cardiac surgery AS Detsky, HB Abrams, JR McLaughlin, DJ Drucker, Z Sasson, ... Journal of general internal medicine 1 (4), 211-219, 1986 | 922 | 1986 |
| Enhancing incretin action for the treatment of type 2 diabetes DJ Drucker Diabetes care 26 (10), 2929-2940, 2003 | 903 | 2003 |
| Glucagon-like peptide-1 receptor signaling modulates β cell apoptosis Y Li, T Hansotia, B Yusta, F Ris, PA Halban, DJ Drucker Journal of Biological Chemistry 278 (1), 471-478, 2003 | 854 | 2003 |
| Incretin-based therapies for type 2 diabetes mellitus JA Lovshin, DJ Drucker Nature Reviews Endocrinology 5 (5), 262-269, 2009 | 853 | 2009 |
| The role of gut hormones in glucose homeostasis DJ Drucker The Journal of clinical investigation 117 (1), 24-32, 2007 | 845 | 2007 |
